Roche acquires Irish biotech firm Inflazome
Swiss pharma company to acquire biotech for $449m (€380m) - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/roche_acquires_irish_biotech_firm_inflazome_1351035
Search results
Found 67 pages
AUTHOR: Lucy Parsons
Bristol Myers Squibb’s Opdivo shows benefit in oesophageal cancers
Data presented at 2020 ESMO virtual congress - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/bristol_myers_squibbs_opdivo_shows_benefit_in_oesophageal_cancers_1351036AZ picks up oral PCSK9 inhibitor programme from Dogma
AZ will take the programme forward into clinical development - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/az_picks_up_oral_pcsk9_inhibitor_programme_from_dogma_1350614CHMP backs seven new meds in September meeting
Positive opinions include Pacira's Exparel and two new vaccines from Sanofi - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/chmp_backs_seven_new_meds_in_september_meeting_1350929GenSight Biologics seeks EU approval for gene therapy
Lumevoq is designed to treat vision loss associated with Leber Hereditary Optic Neuropathy - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/gensight_biologics_seeks_eu_approval_for_gene_therapy_1350373Sanofi, GSK ink deal with EU for 300 million COVID-19 vaccine doses
Upfront funding will be used to scale-up manufacturing - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/sanofi,_gsk_ink_deal_with_eu_for_300_million_covid-19_vaccine_doses_1351087Digital tech has health benefits for dementia patients, project finds
The Leeds Dementia Pathfinder project supported patients and carers with tech devices - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/digital_tech_has_health_benefits_for_dementia_patients,_project_finds_1351078UK’s chief medical officers upgrade coronavirus alert level
Decision made following review of rising COVID-19 cases - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/uks_chief_medical_officers_upgrade_coronavirus_alert_level_1351040Vertex, CRISPR Therapeutics’ sickle cell gene therapy wins PRIME…
European Medicines Agency grants designation based on phase I/II data - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/vertex,_crispr_therapeutics_sickle_cell_gene_therapy_wins_prime_designation_1351077Owlstone Medical’s breath biopsy test improves detection of liver…
Study detected Nonalcoholic Fatty Liver Disease and Nonalcoholic steatohepatitis - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/owlstone_medicals_breath_biopsy_test_improves_detection_of_liver_disease_1351079
